These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

716 related articles for article (PubMed ID: 27511199)

  • 21. Foxf2 in intestinal fibroblasts reduces numbers of Lgr5(+) stem cells and adenoma formation by inhibiting Wnt signaling.
    Nik AM; Reyahi A; Pontén F; Carlsson P
    Gastroenterology; 2013 May; 144(5):1001-11. PubMed ID: 23376422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A genetic study of the role of the Wnt/beta-catenin signalling in Paneth cell differentiation.
    Andreu P; Peignon G; Slomianny C; Taketo MM; Colnot S; Robine S; Lamarque D; Laurent-Puig P; Perret C; Romagnolo B
    Dev Biol; 2008 Dec; 324(2):288-96. PubMed ID: 18948094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequential cancer mutations in cultured human intestinal stem cells.
    Drost J; van Jaarsveld RH; Ponsioen B; Zimberlin C; van Boxtel R; Buijs A; Sachs N; Overmeer RM; Offerhaus GJ; Begthel H; Korving J; van de Wetering M; Schwank G; Logtenberg M; Cuppen E; Snippert HJ; Medema JP; Kops GJ; Clevers H
    Nature; 2015 May; 521(7550):43-7. PubMed ID: 25924068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PTEN loss and KRAS activation leads to the formation of serrated adenomas and metastatic carcinoma in the mouse intestine.
    Davies EJ; Marsh Durban V; Meniel V; Williams GT; Clarke AR
    J Pathol; 2014 May; 233(1):27-38. PubMed ID: 24293351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors.
    Koo BK; Spit M; Jordens I; Low TY; Stange DE; van de Wetering M; van Es JH; Mohammed S; Heck AJ; Maurice MM; Clevers H
    Nature; 2012 Aug; 488(7413):665-9. PubMed ID: 22895187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of R-spondin proteins in cancer biology.
    Ter Steege EJ; Bakker ERM
    Oncogene; 2021 Nov; 40(47):6469-6478. PubMed ID: 34663878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.
    Moon BS; Jeong WJ; Park J; Kim TI; Min do S; Choi KY
    J Natl Cancer Inst; 2014 Feb; 106(2):djt373. PubMed ID: 24491301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HMGA1 amplifies Wnt signalling and expands the intestinal stem cell compartment and Paneth cell niche.
    Xian L; Georgess D; Huso T; Cope L; Belton A; Chang YT; Kuang W; Gu Q; Zhang X; Senger S; Fasano A; Huso DL; Ewald AJ; Resar LMS
    Nat Commun; 2017 Apr; 8():15008. PubMed ID: 28452345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis.
    Zeilstra J; Joosten SP; Dokter M; Verwiel E; Spaargaren M; Pals ST
    Cancer Res; 2008 May; 68(10):3655-61. PubMed ID: 18483247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BCL9-2 promotes early stages of intestinal tumor progression.
    Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W
    Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular Plasticity of Defa4
    Jones JC; Brindley CD; Elder NH; Myers MG; Rajala MW; Dekaney CM; McNamee EN; Frey MR; Shroyer NF; Dempsey PJ
    Cell Mol Gastroenterol Hepatol; 2019; 7(3):533-554. PubMed ID: 30827941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncogenic mutations in intestinal adenomas regulate Bim-mediated apoptosis induced by TGF-β.
    Wiener Z; Band AM; Kallio P; Högström J; Hyvönen V; Kaijalainen S; Ritvos O; Haglund C; Kruuna O; Robine S; Louvard D; Ben-Neriah Y; Alitalo K
    Proc Natl Acad Sci U S A; 2014 May; 111(21):E2229-36. PubMed ID: 24825889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas.
    Schepers AG; Snippert HJ; Stange DE; van den Born M; van Es JH; van de Wetering M; Clevers H
    Science; 2012 Aug; 337(6095):730-5. PubMed ID: 22855427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RSPO3 promotes the aggressiveness of bladder cancer via Wnt/β-catenin and Hedgehog signaling pathways.
    Chen Z; Zhou L; Chen L; Xiong M; Kazobinka G; Pang Z; Hou T
    Carcinogenesis; 2019 Apr; 40(2):360-369. PubMed ID: 30329043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of stemness in a human normal intestinal epithelial crypt cell line by activation of the WNT signaling pathway.
    Guezguez A; Paré F; Benoit YD; Basora N; Beaulieu JF
    Exp Cell Res; 2014 Apr; 322(2):355-64. PubMed ID: 24534551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. R-spondin3-LGR4 signaling protects hepatocytes against DMOG-induced hypoxia/reoxygenation injury through activating β-catenin.
    Liu S; Yin Y; Yu R; Li Y; Zhang W
    Biochem Biophys Res Commun; 2018 Apr; 499(1):59-65. PubMed ID: 29555474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A basal gradient of Wnt and stem-cell number influences regional tumour distribution in human and mouse intestinal tracts.
    Leedham SJ; Rodenas-Cuadrado P; Howarth K; Lewis A; Mallappa S; Segditsas S; Davis H; Jeffery R; Rodriguez-Justo M; Keshav S; Travis SP; Graham TA; East J; Clark S; Tomlinson IP
    Gut; 2013 Jan; 62(1):83-93. PubMed ID: 22287596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Yap-dependent reprogramming of Lgr5(+) stem cells drives intestinal regeneration and cancer.
    Gregorieff A; Liu Y; Inanlou MR; Khomchuk Y; Wrana JL
    Nature; 2015 Oct; 526(7575):715-8. PubMed ID: 26503053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PP2A Deficiency Enhances Carcinogenesis of Lgr5
    Yen YT; Chien M; Lai YC; Chen DP; Chuong CM; Hung MC; Hung SC
    Cells; 2019 Dec; 9(1):. PubMed ID: 31905853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined Mutation of
    Sakai E; Nakayama M; Oshima H; Kouyama Y; Niida A; Fujii S; Ochiai A; Nakayama KI; Mimori K; Suzuki Y; Hong CP; Ock CY; Kim SJ; Oshima M
    Cancer Res; 2018 Mar; 78(5):1334-1346. PubMed ID: 29282223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.